^
BIOMARKER:

CD20 positive

i
Other names: CD20, MS4A1, Membrane Spanning 4-Domains A1, Membrane-Spanning 4-Domains, Subfamily A, Member 1, Leukocyte Surface Antigen Leu-16, B-Lymphocyte Antigen CD20, CD20 Antigen, Membrane-Spanning 4-Domains Subfamily A Member 1, B-Lymphocyte Cell-Surface Antigen B1, B-Lymphocyte Surface Antigen B1, CD20 Receptor, LEU-16, CVID5, MS4A2




Show legend

Include preclinical:
Non-Hodgkin’s Lymphoma
Diffuse Large B Cell Lymphoma
Follicular Lymphoma
B Acute Lymphoblastic Leukemia
Chronic Lymphocytic Leukemia
Lymphoma
Mantle Cell Lymphoma
Childhood B Acute Lymphoblastic Leukemia
Burkitt Lymphoma
Acute Lymphocytic Leukemia
Non Small Cell Lung Cancer
Marginal Zone Lymphoma
Small Lymphocytic Lymphoma
Melanoma
rituximab + blinatumomab
rituximab
rituximab-abbs
rituximab-pvvr
EX103
epcoritamab-bysp
rituximab + copanlisib
obinutuzumab
IMM0306
rituximab-arrx
FCR
R-CHOP
obinutuzumab + INCB50465
Rixathon (rituximab biosimilar)
rituximab + ibritumomab tiuxetan
copanlisib
venetoclax + obinutuzumab
rituximab + ALX148
blinatumomab
rituximab + PF-05082566
MB-106
ofatumumab
rituximab + lenalidomide + epcoritamab-bysp
rituximab + CC-122
durvalumab
rituximab + BMS-986351
pembrolizumab + MVP-S
MRG001
IPH6501
doxorubicin hydrochloride
AR160